Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|March 10, 2016
Hypoglycemia and diabetes: increased need for awarenessCharles Shaefer, Debbie Hinnen, Christopher Sadler
The Journal of Cardiovascular Nursing|February 21, 2012
The role of the kidney in hyperglycemia: a new therapeutic target in type 2 diabetes mellitusDebbie Hinnen
Diabetes Spectrum : a Publication of the American Diabetes Association|May 19, 2018
iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 DiabetesDebbie Hinnen, Jodi Strong
Clinical Diabetes : a Publication of the American Diabetes Association|November 8, 2017
How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?Curtis Triplitt, Debbie Hinnen, Virginia Valentine
Postgraduate Medicine|September 26, 2022
Type 2 diabetes and cardiovascular disease: risk reduction and early interventionDebbie Hinnen, Davida Kruger, Melissa Magwire
Journal of the American Association of Nurse Practitioners|January 26, 2013
Putting medications where they belong: practical advice for managing type 2 diabetes in clinical practiceJeff Unger, Debbie Hinnen, Barbara Schreiner, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 25, 2018
Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to KnowNeil Skolnik, Debbie Hinnen, Yan Kiriakov, et al.
Journal of the American Association of Nurse Practitioners|February 4, 2022
GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practiceLola A Coke, Prakash C Deedwania, Debbie Hinnen, et al.
Journal of Diabetes and Its Complications|January 29, 2021
Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE ControlJohn Anderson, Luigi Meneghini, Debbie Hinnen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 27, 2015
FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1CCharles Shaefer, Timothy Reid, Aleksandra Vlajnic, et al.
Pageof 2